Ptc Therapeutics (PTCT) Intangibles (2017 - 2026)

Ptc Therapeutics' Intangibles history runs 10 years deep, the most recent figure standing at $402.9 million for Q2 2026.

• In Q2 2026, Intangibles rose 180.19% year-over-year to $402.9 million; the TTM figure through Jun 2026 stood at $402.9 million (up 180.19% YoY), while the FY2025 annual figure was $388.8 million, up 227.25% from the prior year.
• Intangibles for Q2 2026 stood at $402.9 million, up from $380.7 million in the prior quarter.
• The five-year high for Intangibles was $763.7 million in Q1 2022, with the low at $118.4 million in Q1 2025.
• The 5-year median for Intangibles is $392.6 million (2025), against an average of $436.7 million.
• The sharpest annual moves came in 2024 and 2025: Intangibles sank 68.7% in 2024, then jumped 227.25% in 2025.
• Ptc Therapeutics' Intangibles stood at $705.9 million in 2022, then tumbled by 46.24% to $379.5 million in 2023, then tumbled by 68.7% to $118.8 million in 2024, then surged by 227.25% to $388.8 million in 2025, then advanced by 3.65% to $402.9 million in 2026.
• Business Quant data shows PTCT's Intangibles at $402.9 million in Q2 2026, $380.7 million in Q1 2026, and $388.8 million in Q4 2025.